Three Oaks Hospice Cares for More Patients Through Series of Acquisitions
Growth fueled by strategic expansion of Texas footprint and entrance into three new states
DALLAS – June 23, 2020 – Three Oaks Hospice, a growing hospice and palliative care company, announced today it has successfully completed four acquisitions since its launch in May 2019 and is poised for continued expansion into additional markets throughout 2020.
The growing Three Oaks Hospice company now includes Houston and Austin, Texas; Chicago; Kansas City and St. Joseph, Mo; and Overland Park, Kan. The company acquired these locations from Peace Hospice and Palliative Care, VeraCare Hospice, Hospice Partners of America and AMED Management.
“Grounded in a collective mission to listen, care and serve, we are committed to building a best-in-class hospice company with a culture focused on patient care, clinical quality, robust technology and superior service,” said Andrea Bohannon, CEO of Three Oaks Hospice. “We have a team of devoted individuals whose perseverance and ingenuity helped us to continue to grow and provide seamless care amid the global pandemic. While operations may look different, it has not changed our spirit and willingness to serve our vast communities.”
Now providing service for more than 200,000 patient days of care annually, Three Oaks Hospice has locations in nine markets and four states including major Texas markets spanning Austin, Dallas, Fort Worth, Houston, and San Antonio. Three Oaks Hospice has plans to enter additional Texas markets over the next 90 days.
“We have done a great job of building our Texas footprint, and we will focus on integrating these new locations and expanding our leadership team to further our employee-centric culture,” Bohannon said. “Then, we will continue to strategically develop other underserved hospice markets outside of Texas.”
Supported by the deep talent of board members and strong capital resources, Three Oaks Hospice will continue throughout the calendar year to execute its strategic plan of entering into new markets via acquisition, while also launching de novo operations in select markets.